Loading…
Inventurus Knowledge Solutions Ltd
NIFTY 500 Smallcap 100 Smallcap 250 Digital
₹27,387 Cr
Market Cap
38.0
P/E
1.27
PEG
36.9%
ROCE
40.3%
ROE
0.34
D/E
26.3%
OPM
⚖️ Compare? ✨ Generate Report 📚 Guides
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
Shareholding
About

Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform

✓ Strengths 2
  • Company has delivered good profit growth of 34.2% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 37.0%
! Concerns 2
  • Stock is trading at 12.4 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
Key Ratios Snapshot
📊 Sector Averages
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
Weak quarter — no financials disclosed; focus entirely on announcing TruBridge acquisition, which adds execution risk but offers long-term upside quarter Investor Presentation One-Pager Mar 2026
What Went Right
  • Strategic rationale for TruBridge acquisition: creates closed-loop healthcare OS with proprietary EHR and AI-powered platform
  • Identified $575M+ whitespace in TruBridge's existing client base for cross-selling RCM and clinical tools
  • Cost synergies targeted ~INR 3000 crore EBITDA for combined entity by FY30 (3-year integration plan)
  • TruBridge assets: TruCode (95% accuracy, $650M+ addressable market) and integrated clearinghouse to reduce third-party fees
  • Transaction expected to be EPS accretive in Year 1 post-closing (Q2-FY27 expected close)
What to Watch
  • No quarterly financial data released — lack of transparency on core business performance and Aquity integration progress
  • TruBridge delayed Q4 results and disclosed accounting errors (immaterial out-of-period adjustments); new auditor issues raised by lawyer advertisements
  • Legacy tech debt: COBOL migration to Postgres is a prerequisite for AI/RCM integration — progress has begun but carries execution risk
  • Post-acquisition leverage ratio ~3x — management claims comfort, but history of rapid deleveraging after Aquity (~2x) does not guarantee same speed
  • Unabated: Aquity integration took 3-4 quarters, and cross-sell was complicated by different decision makers; TruBridge integration timeline is unclear
Management Guidance
  • Target ~INR 3000 crore EBITDA for combined entity by FY30 (3-year post-closing timeframe)
  • Transaction expected to be EPS accretive in Year 1
  • Whitespace opportunity: $440M+ immediate RCM, $575M+ total including platform and clinical
  • Post-acquisition leverage ratio ~3x; management plans to reduce debt within 2 years based on Aquity track record
  • Closing expected in Q2-FY27, subject to approvals
Investor Lens
The thesis shifts from organic growth to a highly leveraged M&A story. The TruBridge acquisition offers a credible platform for cross-selling and margin expansion, but the lack of quarterly numbers raises concerns about underlying momentum. Near-term execution risks include integration of TruBridge (especially COBOL migration), debt load (~3x), and legal noise from TruBridge's accounting lapses. The $575M whitespace is a large upside if delivered, but IKS must prove it can replicate its ambulatory success in acute care. Watch for integration milestones (especially tech stack modernization) and any updates on core IKS revenue growth next quarter.
From investor presentation · AI-generated analysis · Not investment advice
🔒
Premium Feature
Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance
Upgrade to Premium
Already a member? Log in
📈 STRONG Net profit up 39% YoY to ₹206 Cr, margins robust at 34%.
Revenue
Revenue rose 18.5% YoY to ₹858 Cr, driven by strong IT services demand. Sequentially, revenue grew 5.3%, indicating sustained momentum.
Profitability
Net profit surged 39.2% YoY to ₹206 Cr, with EPS improving to ₹12.00 from ₹8.61. PAT growth outpaced revenue, aided by margin expansion and a low tax rate of 19%.
Margins
Operating margin held steady at 34% (YoY improvement from 31%), reflecting operational efficiencies. Operating profit grew 30.5% YoY, reinforcing margin resilience.
Cash Flow
Cash flow data is not disclosed this quarter, limiting insight into cash conversion quality relative to reported profits.
Balance Sheet
Total borrowings stand at ₹766 Cr with reserves of ₹2,224 Cr, giving a low debt-to-equity of 0.34. Total assets of ₹3,606 Cr support a healthy capital base.
Key Risks
High PE of 45.3x leaves little room for earnings disappointments. Any slowdown in IT demand could pressure revenue growth. Debt of ₹766 Cr, though moderate, adds interest cost sensitivity.
Outlook
Consistent double-digit revenue and profit growth, combined with strong ROE of 32.9%, indicate a solid trajectory. However, maintaining margin expansion will be key given competitive IT sector dynamics.
Generated by AI · Mar 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock AI Advisor.

Get 11 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Documents.

Access concall transcripts, annual reports, credit ratings, and investor presentations.

Upgrade to PremiumCreate Free Account

📊 Sector KPIs

Industry-specific KPIs with historical trend — AI-extracted from investor presentations
🔒
Premium Feature
Industry-specific KPIs with historical trend across quarters — AI-extracted from investor presentations
Upgrade to Premium
Already a member? Log in

💼 Management Guidance

Revenue, loan book, NIM and other management targets — with hit/miss tracking
🔒
Premium Feature
Management guidance targets with historical hit/miss tracking — unlocked with Premium
Upgrade to Premium
Already a member? Log in

🎯 Thesis Tracker

Guidance vs Delivery — management track record
🔒
Premium Feature
Management guidance vs actual delivery — track whether revenue & PAT targets were Beat, Met or Missed across every reporting year
Upgrade to Premium
Already a member? Log in
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including equities and mutual funds, involves inherent risks, including the potential loss of principal. All investments are subject to market fluctuations, regulatory changes, and other risks that may affect their value. Past performance is not indicative of future results. This report is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This report does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a SEBI-registered investment adviser or other qualified financial professional before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities or financial instruments discussed in this report. Any such positions, if material, are disclosed to the best of the author's knowledge and are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company, institution, or third party.

Information Sources:
The analysis and opinions expressed herein are based on publicly available information, including but not limited to company filings with the BSE/NSE, annual reports, management commentary, investor presentations, data from the Reserve Bank of India (RBI), SEBI, industry publications, and other reliable financial data sources. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This report may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. The author does not undertake any obligation to update such statements in the future.

Regulatory Compliance:
This report is intended to comply with the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, as amended, and other applicable Indian laws and regulations.

Limitation of Liability:
The content of this report is provided "as is" without any warranties, express or implied, including accuracy, completeness, merchantability, or fitness for a particular purpose. The author and publisher expressly disclaim any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.